Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System (TIARA-I)
Early Feasibility Study of the Neovasc Tiara™ Mitral Transcatheter Heart Valve With the Tiara™ Transapical Delivery System
Sponsor: Shockwave Medical, Inc.
This NA trial investigates Mitral Valve Regurgitation and is currently ongoing. Shockwave Medical, Inc. leads this study, which shows 21 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
21 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting NA
-
Jun 2025 — Sep 2025 [monthly]
Active Not Recruiting NA
-
Mar 2025 — Jun 2025 [monthly]
Active Not Recruiting NA
-
Sep 2024 — Mar 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
▶ Show 16 earlier versions
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Feb 2022 — Jun 2024 [monthly]
Active Not Recruiting NA
-
Sep 2021 — Feb 2022 [monthly]
Active Not Recruiting NA
-
Jun 2021 — Sep 2021 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Jun 2021 [monthly]
Active Not Recruiting NA
-
Oct 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Mar 2020 — Oct 2020 [monthly]
Active Not Recruiting NA
-
Jan 2020 — Mar 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Oct 2019 — Jan 2020 [monthly]
Recruiting NA
-
Mar 2019 — Oct 2019 [monthly]
Recruiting NA
-
Oct 2018 — Mar 2019 [monthly]
Recruiting NA
-
Sep 2018 — Oct 2018 [monthly]
Recruiting NA
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
Nov 2017 — Jun 2018 [monthly]
Recruiting NA
-
Feb 2017 — Nov 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Dec 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Shockwave Medical, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .